Gastro-oesophageal Reflux Disease Trial, Recruiting NCT07506746 Sponsor: IRCCS San Raffaele Condition: Gastro-oesophageal Reflux Disease
Back to Gord

Gastro-oesophageal Reflux Disease Trial, Recruiting

NCT07506746
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are willing and able to give their informed consent to take part in the study
  • People whose procedures are already part of their standard medical care, or who are already taking the relevant medication as part of their normal clinical treatment
  • People aged 18 years or older
  • People experiencing typical reflux symptoms such as heartburn or regurgitation, or less typical symptoms that may be linked to reflux, including throat, voice, ear, sinus, lung, heart, or sleep-related issues, or people experiencing swallowing difficulties, chest pain, or food getting stuck in the throat that may point to a problem with how the oesophagus moves
  • People who have been diagnosed with an inflammatory condition of the oesophagus (such as eosinophilic oesophagitis), a systemic rheumatological condition (such as scleroderma or systemic sclerosis), or who have previously had anti-reflux surgery, weight-loss surgery, or certain endoscopic or surgical procedures on the oesophagus or stomach
  • People who have been referred to the Digestive Physiopathology Unit at IRCCS San Raffaele Hospital for motility testing

Who may not be able to join:

  • People under the age of 18
  • People who are not willing to give their informed consent to be included in the registry

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +390226432643

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
IRCCS San Raffaele
Registry
ClinicalTrials.gov
Start date
9 March 2026
Est. completion
1 March 2031

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

To collect High Resolution Manometry (HRM) data from patients referred for esophageal motility/inflammatory disorders or reflux/obstructive esophageal symptoms at Motility Unit of IRCCS San Raffaele Hospital; To collect pH-impedance data from patients referred for esophageal motility/inflammatory disorders or reflux/obstructive esophageal symptoms at Motility Unit of IRCCS San Raffaele Hospital

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov